Japan Clears Breakthrough Stem-Cell Treatments for Parkinson’s and Heart Failure
Japan has approved a pioneering stem-cell therapy for Parkinson’s disease, marking a major advance in regenerative medicine. The country has also authorised a similar treatment for severe heart failure, potentially making them the first commercially available medical products based on induced pluripotent stem (iPS) cells. These approvals highlight Japan’s leadership in developing advanced biomedical technologies and accelerating the clinical use of regenerative therapies.
Month: Current Affairs - March 07, 2026
Category: Science & Technology